In the present study, we identified a ceRNA network of hsa_circ_0004535/hsa-miR-1827/CASP8 may have an important regulatory role in T2DM with NAFLD. The gene discussed is CASP8; the disease is metabolic dysfunction-associated steatotic liver disease.